JPH08500324A - 治療活性を有するペプチド化合物 - Google Patents

治療活性を有するペプチド化合物

Info

Publication number
JPH08500324A
JPH08500324A JP5511269A JP51126993A JPH08500324A JP H08500324 A JPH08500324 A JP H08500324A JP 5511269 A JP5511269 A JP 5511269A JP 51126993 A JP51126993 A JP 51126993A JP H08500324 A JPH08500324 A JP H08500324A
Authority
JP
Japan
Prior art keywords
ahx
gly
trp
hpa
mephe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5511269A
Other languages
English (en)
Japanese (ja)
Inventor
ピアソン,マイルズ・エドワード
ロザマンド,ジエイムズ・ドナルド
Original Assignee
フアイソンズ・コーポレイシヨン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929220543A external-priority patent/GB9220543D0/en
Priority claimed from GB929220761A external-priority patent/GB9220761D0/en
Application filed by フアイソンズ・コーポレイシヨン filed Critical フアイソンズ・コーポレイシヨン
Publication of JPH08500324A publication Critical patent/JPH08500324A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/595Gastrins; Cholecystokinins [CCK]
    • C07K14/5955Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP5511269A 1991-12-20 1992-12-21 治療活性を有するペプチド化合物 Pending JPH08500324A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US81098591A 1991-12-20 1991-12-20
GB929220543A GB9220543D0 (en) 1992-09-29 1992-09-29 Pharmacologically active compounds
GB07/810.985 1992-10-02
GB929220761A GB9220761D0 (en) 1992-10-02 1992-10-02 Pharmaceutically active compounds
GB9220543.4 1992-10-02
GB9220761.2 1992-10-02
PCT/GB1992/002369 WO1993013126A1 (en) 1991-12-20 1992-12-21 Peptide compounds having therapeutic activity

Publications (1)

Publication Number Publication Date
JPH08500324A true JPH08500324A (ja) 1996-01-16

Family

ID=27266393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5511269A Pending JPH08500324A (ja) 1991-12-20 1992-12-21 治療活性を有するペプチド化合物

Country Status (11)

Country Link
EP (1) EP0619823A1 (enExample)
JP (1) JPH08500324A (enExample)
AU (1) AU672186B2 (enExample)
CA (1) CA2126236A1 (enExample)
FI (1) FI942898A0 (enExample)
HU (1) HU211564A9 (enExample)
IL (1) IL104161A0 (enExample)
MX (1) MX9207458A (enExample)
NO (1) NO942350L (enExample)
NZ (1) NZ246195A (enExample)
WO (1) WO1993013126A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023144717A (ja) * 2022-03-28 2023-10-11 雪印メグミルク株式会社 アンジオテンシン変換酵素阻害ペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754248R (fr) * 1969-08-01 1971-02-01 Farmaceutici Italia Polypeptides a activite
NZ218607A (en) * 1985-12-19 1989-10-27 Pennwalt Corp Tri-to acta-peptides with sulphate ester groups: obesity treatment
IL84478A0 (en) * 1986-11-18 1988-04-29 Pennwalt Corp Peptides with sulfate ester groups and their preparation
DE69017704T2 (de) * 1989-11-27 1995-07-20 Fisons Corp Hexapeptide mit sulphat-ester-gruppen.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023144717A (ja) * 2022-03-28 2023-10-11 雪印メグミルク株式会社 アンジオテンシン変換酵素阻害ペプチド

Also Published As

Publication number Publication date
FI942898L (fi) 1994-06-17
AU3167893A (en) 1993-07-28
NZ246195A (en) 1995-11-27
IL104161A0 (en) 1993-05-13
CA2126236A1 (en) 1993-07-08
NO942350D0 (enExample) 1994-06-20
WO1993013126A1 (en) 1993-07-08
FI942898A7 (fi) 1994-06-17
AU672186B2 (en) 1996-09-26
FI942898A0 (fi) 1994-06-17
HU211564A9 (en) 1995-12-28
MX9207458A (es) 1993-11-01
NO942350L (no) 1994-06-20
EP0619823A1 (en) 1994-10-19

Similar Documents

Publication Publication Date Title
US4737487A (en) VIP type peptides
CA2138161C (en) Glucagon-like peptide and insulinotropin derivatives
US5847066A (en) Analogs of growth hormone-releasing factor
AU636301B2 (en) Cyclic grf-analogs ii
FR2609991A1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments
US4490364A (en) CCK Agonists II
JP2569316B2 (ja) 硫酸エステル基を有するペプチド
JPH0273100A (ja) 医薬用化合物
US4866039A (en) Peptides containing the 18 to 23 residues of vasoactive intestinal peptide, and analogues
JPH08311098A (ja) 新規ペプチド類およびそれを含有するインターロイキン6拮抗剤
HU185321B (en) Process for preparing pharmacologically active ancephaline analogues
EP0381340A2 (en) Peptides with sulphate ester groups
EP0353565A1 (en) Immunostimulating peptides, a process for their preparation and pharmaceutical commpositions containing them
EP0268297A2 (en) Peptides with sulfate ester groups
JPH08500324A (ja) 治療活性を有するペプチド化合物
US5502164A (en) Peptide compounds having therapeutic activity
US4102878A (en) Process for the preparation of the cholecystokinin-pancreozymin octapeptide amide sulfate ester
AU644128B2 (en) Hexapeptides with sulphate ester groups
JP3109835B2 (ja) ペプシンの放出を抑制するためのペプチド
JPS63198699A (ja) スルフエートエステル基を有するペプチド